Shuzhen Mu

Shuzhen Mu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2023 in Bioorganic Chemistry
Verified
Journal Article
Closed access
YFYanhua Fan
Yanhua Fan
FZFeng Zhang
Feng Zhang
LXLiang Xiong
Liang Xiong
MSMingzhi Su
Mingzhi Su
FLFang Luo
Fang Luo
HYHuarong Yang
Huarong Yang

Verified
Journal Article
Open access
PDF file
XXXinglian Xu
Xinglian Xu
LDLulu Deng
Lulu Deng
YTYaling Tang
Yaling Tang
JLJiang Li
Jiang Li
TZTing Zhong
Ting Zhong
Shuzhen MuShuzhen Mu
Shuzhen Mu
Sanguinarine (1) is a natural product with significant pharmacological effects. However, the application of sanguinarine has been limited due to its toxic side effects and a lack of clarity regarding its molecular mechanisms. To reduce the toxic side effects of sanguinarine, its cyanide derivative (1a) was first designed and synthesized in our previous research. In this study, we confirmed that 1a presents lower toxicity than sanguinarine but shows comparable anti-leukemia activity. Further biological studies using RNA-seq, lentiviral transfection, Western blotting, and flow cytometry analysis first revealed that both compounds 1 and 1a inhibited the proliferation and induced the apoptosis of leukemic cells by regulating the transcription of c-MET and then suppressing downstream pathways, including the MAPK, PI3K/AKT and JAK/STAT pathways. Collectively, the data indicate that 1a, as a potential anti-leukemia lead compound regulating c-MET transcription, exhibits better safety than 1 while maintaining cytostatic activity through the same mechanism as 1.